Metastatic Pancreatic Cancer: ASCO Guideline UpdateDavendra Sohal, Daniel A. Laheru, Ignacio Garrido‐Laguna et al.|Journal of Clinical Oncology|2020Cited by 287
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trialDaniel V.T. Catenacci, Yung‐Jue Bang, Yoon‐Koo Kang et al.|The Lancet Oncology|2020Cited by 190
A phase I study of<scp>ABT</scp>‐510 plus bevacizumab in advanced solid tumorsHope E. Uronis, Herbert I. Hurwitz|Cancer Medicine|2013Cited by 28